Reference notes
Coverage
56 journal planning records · 4 policy routes
Sources
Feb. 2026 publisher snapshot · official funder policies
Last reviewed
Policy guidance: September 2026 · data: February 2026
Prepared by the Manusights editorial team.
Publishing-route guide
Open Access Publishing in Biomedicine: APCs, Mandates, and Journal Options
Open-access obligations can change where you submit, which manuscript version you deposit, and whether an APC is actually needed. The answer depends on your award, not a single rule that applies to every funder.
Start with the policy route that applies to your award, then compare the publishing route. The 56-journal dataset is a February 2026 planning snapshot: APCs and institutional agreements change, so verify the current journal price and your library's eligibility before deciding.
Quick orientation
Use this page when the journal decision is constrained by funder policy, APC budget, or the practical route to compliance.
This guide is designed for manuscript planning, not just policy reading. It helps teams map the mandate first, then compare journal models, then check whether institutional agreements or waiver routes change the real cost.
Best used with
Author rights guide
Use it when the next question is what rights you keep after publication or repository deposit.
Journal submission specs
Check journal-level package requirements once the open-access route is clear.
Data sharing requirements
Pair article-access planning with repository and dataset obligations before submission.
In this guide
The five sections that matter most for OA planning
Start with the mandate only if a funder is setting the rules. Most submission teams should move quickly from policy to journal model, then into the APC dataset and the practical cost-reduction routes.
Policy routes
NIH, UKRI, Wellcome, and ERC routes that change how you can publish or deposit.
OA models
Gold, hybrid, and green routes and what each one buys you.
Journal dataset
Compare OA model, approximate APC range, and waiver availability in one place.
APC advice
Budget, waiver, and transformative-agreement choices before acceptance arrives.
Source notes
Know what is approximate, what changes often, and where to verify the latest policy.
Major OA Mandates in Biomedicine
NIH (USA)
Public accessEffective: July 1, 2025 (manuscripts accepted on or after this date)
For in-scope NIH-funded work, the Author Accepted Manuscript must be submitted to PubMed Central upon acceptance and made publicly available without embargo on the official publication date. This is a public-access route; do not assume it requires buying the journal's OA option or that it sets a blanket CC BY licence.
UKRI (UK)
Immediate routeEffective: Research articles submitted on or after April 1, 2022
In-scope research articles may use a compliant immediate-OA publisher route or a repository route for the Author Accepted Manuscript. The open version must carry CC BY or a permitted exception, and a publisher embargo is not permitted for the repository route.
Wellcome Trust
Europe PMCEffective: Current policy updated January 2025
Original research supported by Wellcome must have a version available in Europe PMC on publication under CC BY, with a CC BY-ND exception available in defined cases. Since January 2025, Wellcome funds reasonable APCs only for qualifying fully OA journals or platforms; a compliant Author Accepted Manuscript or preprint route may also be available.
European Research Council (ERC)
Grant-specificEffective: Requirements differ between Horizon 2020 and Horizon Europe grants
For Horizon Europe ERC projects, deposit the accepted manuscript or published version in an open repository and make it available immediately on publication with CC BY or an equivalent licence. Horizon 2020 projects use different deposit and embargo requirements. Read the grant agreement before treating an ERC route as interchangeable with another funder policy.
Practical implication: Do not treat a funder name as a publishing instruction. Confirm the award's scope, the permitted version, required licence, repository, and embargo rule before you submit. A fully OA journal, a hybrid option, or an accepted-manuscript deposit may be viable, but the compliant route is determined by the policy and your journal's terms.
OA Models: Gold, Hybrid, and Green
🟡 Gold OA
The journal is fully open access: all articles are freely available to anyone, immediately on publication. The author (or their funder) pays an APC.
Examples: PLOS ONE, Nature Communications, Genome Biology, eLife
🔵 Hybrid OA
The journal is subscription-based, but authors can pay an additional APC to make their specific article OA. Many subscription journals offer this route.
Examples: Nature, NEJM, Lancet, JAMA, and Cell all offer hybrid OA
🟢 Green OA
The accepted manuscript (not the final typeset PDF) is posted to a repository like PubMed Central, Europe PMC, or an institutional repository. This can avoid an APC, but compliance depends on the funder route and the journal's self-archiving policy.
All major journals permit some version of green OA: embargo periods and version rules vary. Check SHERPA/RoMEO for specific journal policies.
Gold and hybrid open-access options by journal
This February 2026 planning snapshot compares fully open-access journals, hybrid journals with optional OA, approximate APCs, and waiver availability. The default view includes both fully OA and hybrid titles so you can compare the tradeoff directly, then verify the current price and route.
Open access publishing options by journal
A February 2026 planning snapshot. Compare the route that matters first: fully open versus hybrid, approximate APC, and whether the publisher offers a waiver path. Verify live price, agreement eligibility, and policy route before relying on a record.
| Journal | OA model | APC | Waiver |
|---|---|---|---|
| PLOS ONE | Gold OA | $1,931 | Yes |
| PLOS Medicine | Gold OA | $3,500 | Yes |
| eLife | Gold OA | ~$2,000 | Yes |
| Nature Communications | Gold OA | $9,750 | No |
| Science Advances | Gold OA | $5,000 | No |
| Genome Biology | Gold OA | $2,890 | Yes |
| BMC Medicine | Gold OA | $3,290 | Yes |
| Scientific Reports | Gold OA | $2,490 | No |
| Frontiers in Immunology | Gold OA | $1,299 | No |
| BMJ Open | Gold OA | $2,500 | Yes |
| The Lancet | Hybrid OA | ~$5,500 | No |
| NEJM | Hybrid OA | ~$6,000 | No |
| JAMA | Hybrid OA | ~$4,500 | No |
| Nature Medicine | Hybrid OA | ~$11,690 | No |
| Nature | Hybrid OA | ~$11,690 | No |
| Science | Hybrid OA | ~$4,500 | No |
| Cancer Cell | Hybrid OA | ~$9,900 | No |
| The BMJ | Hybrid OA | ~$4,200 | No |
| Cell | Hybrid OA | ~$9,900 | No |
| Nature Biotechnology | Hybrid OA | ~$11,690 | No |
| Journal of Clinical Oncology | Hybrid OA | ~$4,000 | No |
| Circulation | Hybrid OA | ~$4,500 | No |
| European Heart Journal | Hybrid OA | ~$4,000 | No |
| The Lancet Oncology | Hybrid OA | ~$5,500 | No |
| Cell Metabolism | Hybrid OA | ~$9,900 | No |
| Nature Genetics | Hybrid OA | ~$11,690 | No |
| Nature Immunology | Hybrid OA | ~$11,690 | No |
| Nature Neuroscience | Hybrid OA | ~$11,690 | No |
| Immunity | Hybrid OA | ~$9,900 | No |
| Gastroenterology | Hybrid OA | ~$4,000 | No |
| GUT | Hybrid OA | ~$4,200 | No |
| JACC | Hybrid OA | ~$4,500 | No |
| Lancet Infectious Diseases | Hybrid OA | ~$5,500 | No |
| JAMA Oncology | Hybrid OA | ~$4,500 | No |
| Lancet Neurology | Hybrid OA | ~$5,500 | No |
| Cell Host & Microbe | Hybrid OA | ~$9,900 | No |
| Cell Stem Cell | Hybrid OA | ~$9,900 | No |
| Nature Methods | Hybrid OA | ~$11,690 | No |
| Neuron | Hybrid OA | ~$9,900 | No |
| Circulation Research | Hybrid OA | ~$4,500 | No |
| Molecular Cell | Hybrid OA | ~$9,900 | No |
| JAMA Cardiology | Hybrid OA | ~$4,500 | No |
| Hepatology | Hybrid OA | ~$4,000 | No |
| Journal of Clinical Investigation | Hybrid OA | ~$3,500 | No |
| Nature Chemical Biology | Hybrid OA | ~$11,690 | No |
| Science Translational Medicine | Hybrid OA | ~$4,500 | No |
| Nature Structural & Molecular Biology | Hybrid OA | ~$11,690 | No |
| Brain | Hybrid OA | ~$3,500 | No |
| The EMBO Journal | Hybrid OA | ~$5,000 | No |
| Molecular Psychiatry | Hybrid OA | ~$11,690 | No |
| Current Biology | Hybrid OA | ~$9,900 | No |
| Developmental Cell | Hybrid OA | ~$9,900 | No |
| Blood | Hybrid OA | ~$4,500 | No |
| PNAS | Hybrid OA | ~$2,250 | Yes |
| Cell Reports | Hybrid OA | ~$9,900 | No |
| Nucleic Acids Research | Hybrid OA | ~$3,000 | No |
Practical Advice on APCs
Check institutional agreements first
Many research universities have read-and-publish agreements with Springer Nature, Wiley, Elsevier, and other publishers that let corresponding authors publish OA at no direct cost. Before paying an APC out of pocket, ask your library whether a transformative agreement covers your target journal. Many researchers don't know these agreements exist.
Budget OA costs before you submit
If your grant requires open access, budget for APC costs in your grant application. Eligible publication costs depend on the award and policy. Ask your grants office or library before treating an APC as covered, and do it before acceptance creates time pressure.
Waivers are real and underused
PLOS and BMC both have formal waiver programs. Researchers at institutions without library subscriptions or in low-income countries often qualify. Even where formal waivers don't exist, editors at some journals have discretion: if you're unfunded, it doesn't hurt to ask.
Preprint posting is free
Posting to bioRxiv or medRxiv can make work visible while it is under review, and a preprint can be part of a compliant route for some funders. It does not automatically satisfy every funder or journal requirement. Check the policy and the target journal's terms before relying on it.
Data Sources & Disclaimers
- • APC figures: A February 2026 publisher-price snapshot, not a live quote. APCs, currency treatment, and agreement eligibility change regularly. Verify the journal's current author instructions and your institution's route before submission.
- • Policy information: Reviewed against the linked NIH, UKRI, Wellcome, and ERC guidance in September 2026. Policies and award terms evolve; the current funder page and grant agreement control.
- • Institutional agreements: Coverage varies by institution and changes as agreements are negotiated. Your library is the authoritative source.
- • Impact factors: Clarivate JCR 2024.
- • Journal routes: A journal appearing in this table is not a compliance certification. The route can depend on the manuscript version, funder, corresponding author, licence, repository, and agreement terms.
References
- Budapest Open Access Initiative. (2002). Budapest Open Access Initiative. Open Society Institute. [budapestopenaccessinitiative.org ↗]
- National Institutes of Health. (2025). NIH Public Access Policy overview. U.S. Department of Health and Human Services. [grants.nih.gov ↗]
- UK Research and Innovation. (2026). Making your research article open access. [ukri.org ↗]
- Wellcome. (2025). Complying with our open access policy. [wellcome.org ↗]
- SHERPA/RoMEO. (2026). Publisher copyright and self-archiving policies database. Jisc. [sherpa.ac.uk/romeo ↗]
- Creative Commons. (2013). Attribution 4.0 International (CC BY 4.0) License. [creativecommons.org ↗]
- European Research Council. (2026). Open science in ERC projects. [erc.europa.eu ↗]
Practical note
Three mistakes that make OA planning harder than it needs to be
Cite this resource
Citation formats
Free to use and cite, with attribution. See the reuse policy for what you may republish.
- APA
- Manusights. (2026). Open access publishing in biomedicine: APCs, mandates, and journal options (Policy guidance reviewed September 2026; journal data snapshot February 2026). https://manusights.com/resources/open-access-guide
- MLA
- Manusights. "Open Access Publishing in Biomedicine: APCs, Mandates, and Journal Options." Manusights, policy guidance reviewed Sept. 2026; journal data snapshot Feb. 2026, manusights.com/resources/open-access-guide.
- Vancouver
- Manusights. Open access publishing in biomedicine: APCs, mandates, and journal options [Internet]. Policy guidance reviewed Sep 2026; journal data snapshot Feb 2026. Available from: https://manusights.com/resources/open-access-guide
Related reference pages
Author Rights and Copyright
Use this when the open-access question shifts from APCs to what rights you keep after publication.
Data Sharing Requirements
Pair funder mandate planning with repository and data-availability requirements.
Reference Library
Return to the full publishing reference library for timelines, acceptance rates, and submission specs.
Frequently Asked Questions
What is the difference between gold, green, and diamond open access?
Gold open access means the final published version is immediately freely available, typically funded by an article processing charge (APC) paid by the author or their institution. Green open access means the author self-archives an accepted manuscript version in a repository (institutional or subject-based like PubMed Central) after a publisher embargo period, with no APC required. Diamond open access is a subset of gold where neither authors nor readers pay - the journal is funded by institutions, grants, or societies. Most major subscription journals now offer a hybrid gold option for authors who need to comply with funder mandates.
Do I have to pay an APC to publish open access?
Not always. APC eligibility depends on your funder, award, journal, and institutional agreement. For example, Wellcome funds reasonable APCs only for qualifying fully OA venues, while many institutions have publisher agreements that may cover eligible corresponding authors. A compliant repository route can avoid an APC for some funder policies, but check the policy and journal terms before relying on it. Diamond OA journals charge no APC and some publishers offer waivers. Before paying out of pocket, ask your library about eligible agreements and check your funder's current guidance.
Which Creative Commons license should I choose for my open access paper?
Start with your funder and award conditions, because licences are not uniform. UKRI requires CC BY for an in-scope research article's open version, with limited permitted exceptions. Wellcome requires CC BY for original research, with a CC BY-ND exception in defined cases. NIH's public-access policy should not be treated as a blanket CC BY requirement. CC BY permits sharing and adaptation with attribution; CC BY-NC restricts commercial reuse; CC BY-ND restricts derivatives. Confirm the licence offered by the journal and required by your funder before submission.